Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 43,100 people in 79 countries and markets its products in more than 170 countries. In the Philippines, Novo Nordisk started its operations in 1976 under the umbrella organization of its distributor. In 1999, steps were taken to establish an affiliate office in the Philippines with the vision of making Novo Nordisk a market leader in its areas of expertise. In June 30, 1999, the Philippine Office was finally able to obtain approval from the Securities and Exchange Commission to operate as an independent Pharmaceutical Company.